| 5-FU | 5-fluorouracil |
| ALL | Acute lymphoblastic leukemia |
| AML | Acute myeloid leukemia |
| AMPK | 5′ AMP-activated protein kinase |
| ATP | Adenosine triphosphate |
| BSO | L-buthionine sulfoximine |
| ccRCC | Clear cell renal cell carcinoma |
| CRC | Colorectal cancer |
| DBZ | Dibenzozepine |
| EGFR | Epidermal growth factor receptor |
| ERK | Extracellular signal-regulated kinase |
| GA | Glutaminase |
| GBM | Glioblastoma |
| Gln | Glutamine |
| Glu | Glutamate |
| GLS | Glutaminase isoenzyme 1 |
| GLS2 | Glutaminase isoenzyme 2 |
| GS | Glutamine synthetase |
| GSH | Glutathione |
| GSI | Gamma-secretase inhibitor |
| HNSCC | Head and neck squamous cell carcinomas |
| LDHA | Lactate dehydrogenase A |
| NQO1 | NAD(P)H quinone oxidoreductase 1 |
| NRF2 | Nuclear factor erythroid 2-related factor 2 |
| NSCLC | Non-small cell lung cancer |
| OXPHOS | Oxidative phosphorylation |
| PD-1 | Programmed cell death protein 1 |
| PET | Positron emission tomography |
| PDK | Pyruvate dehydrogenase kinase |
| PDAC | Pancreatic ductal adenocarcinoma |
| PDO | Patient-derived organoids |
| PDX | Patient-derived xenografts |
| PD-1 | Programmed cell death protein 1 |
| PD-L1 | Programmed cell death ligand 1 |
| PROTAC | Proteolysis Targeting Chimera |
| RCC | Renal cell carcinoma |
| ROS | Reactive oxygen species |
| SCC | Squamous cell carcinoma |
| T-ALL | T-cell acute lymphoblastic leukemia |
| TAM | Tumor-associated macrophage |
| TCA | Tricarboxylic acid |
| TKI | Tyrosine kinase inhibitor |
| TME | Tumor microenvironment |
| TNBC | Triple negative breast cancer |